Literature DB >> 3046968

Measurement of L-[1-14C]leucine kinetics in splanchnic and leg tissues in humans. Effect of amino acid infusion.

R A Gelfand1, M G Glickman, P Castellino, R J Louard, R A DeFronzo.   

Abstract

Although whole-body leucine flux is widely measured to study body protein turnover in humans, the contribution of specific tissues to the total-body measurement remains unknown. By combining the organ-balance technique with the systemic infusion of L-[1-14C]leucine, we quantitated leucine production and disposal by splanchnic and leg tissues and by the whole body, simultaneously, in six normal men before and during amino acid infusion. At steady state, disposal of arterial leucine by splanchnic and leg tissues was calculated from the percent extraction (E) of L-[1-14C]leucine counts: uptake = E x [Leu]a x flow. Tissue release of cold leucine (from protein turnover) into vein was calculated as the difference between leucine uptake and the net tissue leucine balance. In the postabsorptive state, despite substantial (P less than .01) extraction of L-[1-14C]leucine by splanchnic (23 +/- 1%) and leg (18 +/- 2%) tissues, net leucine balance across both tissue beds was small, indicating active simultaneous disposal and production of leucine at nearly equivalent rates. Splanchnic tissues accounted for approximately 50% of the measured total-body leucine flux. During amino acid infusion, the net leucine balance across splanchnic and leg tissues became positive, reflecting not only an increase in leucine uptake but also a marked suppression (by approximately 50%, P less than .02) of cold leucine release. This reduction in splanchnic and leg leucine release was indicated by a sharp decline in whole-body endogenous leucine flux.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046968     DOI: 10.2337/diab.37.10.1365

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes.

Authors:  Jill A Bell; Elena Volpi; Satoshi Fujita; Jerson G Cadenas; Melinda Sheffield-Moore; Blake B Rasmussen
Journal:  J Nutr       Date:  2006-05       Impact factor: 4.798

2.  Regulation of glucose and protein metabolism in growing steers by long-chain n-3 fatty acids in muscle membrane phospholipids is dose-dependent.

Authors:  M Fortin; P Julien; Y Couture; P Dubreuil; P Y Chouinard; C Latulippe; T A Davis; M C Thivierge
Journal:  Animal       Date:  2010-01       Impact factor: 3.240

3.  Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man.

Authors:  P Tessari; S Inchiostro; G Biolo; E Vincenti; L Sabadin
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 4.  Effect of intravenous amino acids on protein kinetics in preterm infants.

Authors:  Satish C Kalhan; John M Edmison
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-01       Impact factor: 4.294

5.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.

Authors:  A Consoli; N Nurjhan; J J Reilly; D M Bier; J E Gerich
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics.

Authors:  P Tessari; G Garibotto; S Inchiostro; C Robaudo; S Saffioti; M Vettore; M Zanetti; R Russo; G Deferrari
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.

Authors:  K S Nair; G C Ford; K Ekberg; E Fernqvist-Forbes; J Wahren
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle.

Authors:  R J Louard; D A Fryburg; R A Gelfand; E J Barrett
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms.

Authors:  D A Fryburg; L A Jahn; S A Hill; D M Oliveras; E J Barrett
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

10.  Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle.

Authors:  G Biolo; R Y Declan Fleming; R R Wolfe
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.